Secondary Logo

April 2019 - Volume 42 - Issue 3

  • Steven A. Rosenberg, MD, PhD
  • 1524-9557
  • 1537-4513
  • 9 issues per year
  • Oncology 79/217
    Immunology 55/150
    Medicine, Research, and Experimental 37/128
  • 3.826

Current Issue Highlights



Chimeric Antigen Receptor-modified Donor Lymphocyte Infusion Improves the Survival of Acute Lymphoblastic Leukemia Patients With Relapsed Diseases After Allogeneic Hematopoietic Stem Cell Transplantation

Wang, Tao; Gao, Lei; Hu, Xiaoxia; More

Journal of Immunotherapy. 42(3):81-88, April 2019.